Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects
- Status
- COMPLETED
- Phase
- PHASE3
UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Southeastern Diabetes Initiative Clinical Intervention
- Status
- COMPLETED
- Phase
- NA
Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Therapeutic Option for Hepatitis B and C: a French Cohort
- Status
- UNKNOWN
- Phase
- N/A
Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)
- Status
- COMPLETED
- Phase
- PHASE4
Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
- Status
- COMPLETED
- Phase
- N/A
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4